The Best in Science News and Amazing Breakthroughs
drugs on a wide range of health issues including dementia and cardiovascular diseases, although experts warned against seeing them as miracle drugs.is unique in its scope, marking a milestone in the study of new-generation weight-loss drugs such as Ozempic, Wegovy and Mounjaro, which have already somewhat revolutionised the fight against obesity.
Monday's vast study confirmed the findings of the previous research, also bringing more specific information about the drugs' promising effects. The GLP-1 patients had"a lower risk of drug use, psychological or convulsive disorders, neurocognitive disorders, including The study drew its observations from people who were prescribed the medication, and doesn't allow for the establishment of a causal link between the drugs and the diseases.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Elon Musk admits to taking weight-loss drug while dressed as 'Ozempic Santa' on ChristmasElon Musk admits to taking weight-loss drug while dressed as ‘Ozempic Santa’ on Christmas
Read more »
Ozempic: A Weight Loss Wonder Drug or a Troubling Trend?The author explores the controversial rise of Ozempic for weight loss, questioning its long-term effects and societal implications.
Read more »
6 Best Weight Loss Treatments: Ranking Top Weight Loss Solutions of 2025Affiliate. Explore the top six weight loss brands currently on the market in 2025.
Read more »
I’m a weight loss doctor—the unusual complication I’m seeing from Ozempic-like drugsA top NYC weight-loss doctor shared the surprising skin complication that he’s encountered in patients using GLP-1 drugs like Ozempic.
Read more »
Medicare to Negotiate Prices for Weight Loss Drugs Ozempic and WegovyThe Biden administration announced that popular weight loss drugs Ozempic and Wegovy will be included in Medicare's price negotiation program. This move is expected to result in billions of dollars in savings for taxpayers, with negotiations handled by the incoming Trump administration.
Read more »
The benefits of Ozempic and its kin may extend far beyond weight lossStudies suggest that semaglutide reduces heart attack and stroke and may curb addiction and more. Scientists reflect on the future of GLP-1 drugs beyond weight loss.
Read more »